|
Natco Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
14555.36 Cr.
|
P/BV
|
1.91
|
Book Value (Rs.)
|
424.71
|
|
52 Week High/Low (Rs.)
|
1505/727
|
FV/ML
|
2/1
|
P/E(X)
|
7.72
|
|
Bookclosure
|
20/11/2025
|
EPS (Rs.)
|
105.26
|
Div Yield (%)
|
0.74
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 4411.60 | 3978.80 | 2696.90 | 1904.90 | 1690.30 |
| Other Operating Revenues | 17.90 | 20.00 | 10.20 | 39.90 | 361.80 |
| Total Operating Revenues | 4429.50 | 3998.80 | 2707.10 | 1944.80 | 2052.10 |
| | | | | | |
| Other Income | 354.50 | 128.10 | 104.60 | 99.00 | 103.60 |
| Total Revenue | 4784.00 | 4126.90 | 2811.70 | 2043.80 | 2155.70 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 536.20 | 522.50 | 475.30 | 519.20 | 372.90 |
| Purchase Of Stock-In Trade | 166.10 | 151.40 | 175.70 | 58.50 | 186.60 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -12.50 | 42.70 | -23.70 | -16.80 | -48.10 |
| Employee Benefit Expenses | 594.50 | 525.00 | 486.70 | 444.80 | 414.90 |
| Finance Costs | 23.90 | 19.20 | 14.50 | 17.70 | 13.30 |
| Depreciation And Amortisation Expenses | 235.20 | 186.80 | 163.80 | 142.60 | 116.90 |
| Other Expenses | 949.20 | 1005.80 | 657.50 | 675.60 | 519.60 |
| Total Expenses | 2492.60 | 2453.40 | 1949.80 | 1841.60 | 1576.10 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2291.40 | 1673.50 | 861.90 | 202.20 | 579.60 |
| | | | | | |
| Profit/Loss Before Tax | 2291.40 | 1673.50 | 861.90 | 202.20 | 579.60 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 437.60 | 316.50 | 162.70 | 47.80 | 147.80 |
| Deferred Tax | -29.60 | -31.30 | -16.10 | -15.60 | -10.60 |
| Total Tax Expenses | 408.00 | 285.20 | 146.60 | 32.20 | 137.20 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1883.40 | 1388.30 | 715.30 | 170.00 | 442.40 |
| | | | | | |
| Profit/Loss From Continuing Operations | 1883.40 | 1388.30 | 715.30 | 170.00 | 442.40 |
| | | | | | |
| Profit/Loss For The Period | 1883.40 | 1388.30 | 715.30 | 170.00 | 442.40 |
| | | | | | |
| Minority Interest | 2.00 | 0.00 | 0.00 | 0.00 | -1.50 |
| Consolidated Profit/Loss After MI And Associates | 1885.40 | 1388.30 | 715.30 | 170.00 | 440.90 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 105.26 | 77.34 | 39.18 | 9.32 | 24.20 |
| Diluted EPS (Rs.) | 105.26 | 77.34 | 39.18 | 9.32 | 24.16 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 107.50 | 170.20 | 100.40 | 82.10 | 113.80 |
